MIR — Mirion Technologies, Inc. stock price, charts and financials

QT20Mirion Technologies, Inc.

Mirion Technologies, Inc. (NYSE: MIR) is a Industrials company in the Industrial - Machinery industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
15.76
-0.48-2.96%
MIRQT20Mirion Technologies, Inc.·NYSE
15.76-2.96%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E175.11EPS (ttm)0.09Insider Own33.90%Shs Outstand243.28MPerf Week-1.38%
Market Cap3.83BForward P/E23.61EPS next Y0.67Insider Trans0.01%Shs Float223.97MPerf Month1.03%
Enterprise Value4.64BPEG9.07EPS next Q0.12Inst Own-Short Float16.03%Perf Quarter-15.31%
Income25.00MP/S3.74EPS this Y505.67%Inst Trans-Short Ratio9.06Perf Half Y-19.96%
Sales1.02BP/B2.04EPS next Y22.45%ROA0.70%Short Interest35.91MPerf YTD-32.71%
Book/sh7.71P/C9.02EPS next 5Y19.31%ROE1.33%52W High30.28 -47.95%Perf Year-30.57%
Cash/sh1.75P/FCF28.42EPS past 3/5Y-ROIC1.41%52W Low14.11 11.69%Perf 3Y107.10%
Dividend Est.-EV/EBITDA21.46Sales past 3/5Y8.81% -Gross Margin48.00%Volatility4.54% 4.11%Perf 5Y56.97%
Dividend TTM-EV/Sales4.52EPS Y/Y TTM150.00%Oper. Margin5.32%ATR (14)0.71Perf 10Y-
Dividend Ex-Date-Quick Ratio2.63Sales Y/Y TTM19.05%Profit Margin2.39%RSI (14)49.62Recom2.11
Dividend Gr. 3/5Y-Current Ratio3.20EPS Q/Q9.09%SMA200.88%Beta1.08Target Price23.60
Payout0.00%Debt/Eq0.64Sales Q/Q19.73%SMA500.08%Rel Volume1.88Prev Close16.24
Employees3,281LT Debt/Eq0.64EarningsOct 27SMA200-19.71%Avg Volume3.99MPrice15.76
IPO DateAug 20, 2020Option/ShortYes / YesEPS/Sales Surpr.16.03% -0.93%Net Debt/EBITDA3.78Volume7,502,132Change-2.96%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-03-26InitiatedJefferiesBuy$20
Aug-10-26ReiteratedMorgan StanleyEqual Weight$25$23
Jul-30-26ReiteratedNorthland SecuritiesOutperform$29$24
Jul-29-26ReiteratedGoldman SachsBuy$25$23
Jul-13-26ReiteratedMorgan StanleyEqual Weight$27$25
Jul-10-26ReiteratedGoldman SachsBuy$29$25
May-04-26ReiteratedEvercore ISI GroupOutperform$29$28
Mar-11-26ReiteratedMorgan StanleyEqual Weight$29$27
Feb-13-26ReiteratedRobert W. Baird$30$29
Feb-12-26ReiteratedGoldman SachsBuy$34$29
Latest News· Times ET
Sep-11-26
Sep-08-26
Sep-04-26
Sep-03-26
Aug-31-26
Aug-24-26
Aug-21-26
Aug-13-26
Aug-11-26
Aug-10-26
Aug-05-26
Aug-04-26
Aug-03-26
Jul-29-26
Company

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
6/30/2018
Total Revenue1,025925861
Cost of Goods Sold Incl. D&A534487459
Gross Profit492439402
Selling, General and Administrative Excl. Other398348338
Research and Development403935
Other Operating Expense-104
Operating Income555225
Interest Expense344258
Unusual Expense
Non-Operating Income (Expense)1223-1
Net Income Before Taxes3033-34
Income Taxes433
Consolidated Net Income2529-36
Net Income From Continuing Operations2630-37
Net Income2529-36
EPS (Recurring)0.100.13-0.18
EPS (Basic, Before Extraordinaries)0.100.13-0.18
EPS (Diluted)0.090.11-0.18
EBITDA216213179
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio175.11212.91
Price To Sales Ratio3.775.824.15
Gross Margin48.0047.4646.69
Operating Margin5.375.622.90
Net Margin2.443.14-4.18
Shares Outstanding245230205
Market Capitalization3,8615,3873,577
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$32.05$27.06$22.08$17.09$12.10 Close Price0.00M2.87M5.74M8.61M11.48MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Schopfer BrianChief Financial OfficerSep 02 '26Buy15.6020,000312,000933,290Sep 02
Moore Christopher A.Chief Accounting Officer (PAO)May 07 '26Sale19.648,400164,97622,157May 08
Kingsley Lawrence DDirectorDec 10 '25Sale24.73350,0008,654,8003,509,075Dec 12
Kingsley Lawrence DDirectorNov 21 '25Sale23.83300,0007,148,4003,900,000Nov 21
Eloy LoicNuclear & Safety PresidentNov 11 '25Sale27.2445,0001,225,68397,770Nov 12
Lee EmmanuelleChief Legal OfficerNov 10 '25Sale27.4112,500342,64384,640Nov 12
Schopfer BrianChief Financial OfficerNov 06 '25Sale27.65100,0002,765,420904,432Nov 10
Logan Thomas DChief Executive OfficerAug 12 '25Sale21.79175,0003,813,6353,567,305Aug 13
Logan Thomas DChief Executive OfficerAug 11 '25Sale21.31325,0006,927,1483,742,305Aug 13
Eloy LoicNuclear & Safety PresidentAug 05 '25Sale21.3022,166472,138142,770Aug 06
Schopfer BrianChief Financial OfficerJun 25 '25Sale21.0075,0001,575,000919,432Jun 27
Kingsley Lawrence DDirectorMay 21 '25Sale17.94500,0008,972,3500May 23
Schopfer BrianChief Financial OfficerMay 21 '25Sale18.2775,0001,370,003919,432May 23
Eloy LoicTechnologies Group PresidentDec 13 '24Sale17.8944,000787,160133,663Dec 17
Lee EmmanuelleChief Legal OfficerOct 31 '24Sale14.273,40548,6030Nov 04
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.